−£696k
−7365%vs Jun 2024Active09621004Private limited companyLondon
LOULOU FOUNDATION
Significant control: Abdulmajid Abdulhamid Dhia Jafar (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Loulou Foundation: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Loulou Foundation sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
LOULOU FOUNDATION is an active private limited company (company number 09621004) incorporated on 3 June 2015, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of −£696k and cash of £1.45m, with 0 employees on average. Net assets fell 7365% on the prior period (£9,585).
Peer position · net assets
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Abdulmajid Abdulhamid Dhia Jafar
- has significant influence or control
- Lynn Jafar
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 June 201511 yrs ago
- Next accounts due
- 30 March 2027in 154 days
- Confirmation statement due
- 17 June 2027in 233 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£1.45m
−44%vs Jun 2024Not reported
0
vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£696k | £1.45m | £10.08m | £2.32m | — | — | 0 |
| 30 June 2024 | £9,585 | £2.58m | £9.59m | £2.58m | — | — | 0 |
Current ratio4.97Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-696,333 at 30 June 2025
- Net assets down 25% or more on the prior period-7364.8% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.97
- Cash at bank of £50,000 or moreCash £1,446,275
- Incorporated five or more years agoIncorporated 3 June 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 233 days
- Next accounts duein 154 days
- Accounts period endNet liabilities £696k · small accounts
- Accounts period endNet assets £9,585 · small accounts
- Incorporated
08
Similar companies in London
- PURAFFINITY LTDLondon · inc. Jun 2015
- OPPILAN PHARMA LIMITEDLondon · inc. May 2015
- MICROFLO SCIENTIFIC LIMITEDEaling · inc. May 2015
- SERES THERAPEUTICS UK LIMITEDLondon · inc. Jun 2015
- MEREO BIOPHARMA 2 LIMITEDLondon · inc. Jun 2015
- MEREO BIOPHARMA 1 LIMITEDLondon · inc. Jun 2015
All companies incorporated on 3 June 2015 · in Jun 2015.
09
Reminders for LOULOU FOUNDATION
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.